X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Orchid Chemicals Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Quarterly Results   (ORCHID)

Here are the latest quarterly results of Orchid Chemicals. For more details, see the Orchid Chemicals financial fact sheet and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Chemicals Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,0841,9091,8771,8002,0491,3962,0931,442 
Other income Rs m92006286544784 
Turnover Rs m2,1761,9091,8771,8622,1341,4502,1411,526 
Expenses Rs m1,7401,7921,6231,5471,9921,7181,8561,306 
Gross profit Rs m3451172542533,4732,3041,8501,890 
Depreciation Rs m351345347352349336336335 
Interest Rs m7136927126941,213709755762 
Profit before tax Rs m-628-920-805-7321,9971,313806877 
Tax Rs m10-120-120-122119169103105 
Profit after tax Rs m-637-800-685-6101,8791,145703772 
Gross profit margin %16.56.113.514.0169.5165.088.4131.0 
Effective tax rate %-1.513.014.916.75.912.812.711.9 
Net profit margin %-30.6-41.9-36.5-33.991.782.033.653.5 
Diluted EPS Rs -7.5 -9.4 -8.0 -7.2 22.0 13.4 8.3 9.1  
Diluted EPS (TTM) Rs -32.2 -36.0 -35.9 -32.1 -2.5 20.3 36.6 52.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   J.B.CHEMICALS  GSK PHARMA  CIPLA  PANACEA BIOTECH  GLENMARK PHARMA  

Compare ORCHID PHARMA LTD With:   J.B.CHEMICALS  GSK PHARMA  CIPLA  PANACEA BIOTECH  GLENMARK PHARMA  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; IT Stocks Lead Gains(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in above the dotted line.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 20, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - ASTRAZENECA PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS